Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Cells · 04.02.2025 · 14 (3) · 221
DOI: 10.3390/cells14030221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.02.2025. Verfasst von Jiatong Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Queen Mary School, Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Cigarette Smoking, Smoke, Smoking. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, School of Basic Medical Sciences, Nanchang University.
Abstract (Originalsprache)
Cigarette smoke (CS), an intricate blend comprising over 4000 compounds, induces abnormal cellular reactions that harm multiple tissues. Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease (CLD), encompassing non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Recently, the term NAFLD has been changed to metabolic dysfunction-associated steatotic liver disease (MASLD), and NASH has been renamed metabolic dysfunction-associated steatohepatitis (MASH). A multitude of experiments have confirmed the association between CS and the incidence and progression of MASLD. However, the specific signaling pathways involved need to be updated with new scientific discoveries. CS exposure can disrupt lipid metabolism, induce inflammation and apoptosis, and stimulate liver fibrosis through multiple signaling pathways that promote the progression of MASLD. Currently, there is no officially approved efficacious pharmaceutical intervention in clinical practice. Therefore, lifestyle modifications have emerged as the primary therapeutic approach for managing MASLD. Smoking cessation and the application of a series of natural ingredients have been shown to ameliorate pathological changes in the liver induced by CS, potentially serving as an effective approach to decelerating MASLD development. This article aims to elucidate the specific signaling pathways through which smoking promotes MASLD, while summarizing the reversal factors identified in recent studies, thereby offering novel insights for future research on and the treatment of MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Queen Mary School, Medical College, Nanchang University, Nanchang 330006, China.
- Department of Histology and Embryology, Jiangxi Medical College, Nanchang University, Nanchang 330019, China.
Förderung
- National Natural Science Foundation of China
- School of Basic Medical Sciences, Nanchang University
Zitieren
APA
Xu, J., Li, Y., Feng, Z., & Chen, H. (2025). Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy. Cells, 14(3), 221. https://doi.org/10.3390/cells14030221
Vancouver
Xu J, Li Y, Feng Z, Chen H. Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy. Cells. 2025;14(3):221. doi:10.3390/cells14030221
BibTeX
@article{Xu2025,
author = {Xu, Jiatong and Li, Yifan and Feng, Zixuan and Chen, Hongping},
title = {Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy},
journal = {Cells},
year = {2025},
volume = {14},
number = {3},
pages = {221},
doi = {10.3390/cells14030221}
}
EUVIMED